Top Pharma Forecasting Experts lined up for eyeforpharma Forecasting Excellence Summit

eyeforpharmaThe eyeforpharma Forecasting Excellence Summit USA 2007 will take place at Boston, October 25th-26th 2007.
eyeforpharma, world leader in organizing events and providing business information for the Pharmaceutical Industry, has announced a top line up of speakers for the forthcoming Pharma Forecasting Excellence Summit USA 2007.

The list includes:
Bob Draper, Forecasting Director, Eli Lilley
Sanjiv Sharma, VP Commercial Affairs, Nicox Pharma
Etienne Adrianssen, Director of Strategic Planning and Portfolio Management, Nycomed
Stephan Malvolti, Global Head of Forecasting, Novartis
Lars Nordmann, Director of Forecasting, Organon USA

With over 200 Pharma executives already registered and with the event nearly sold out the Summit promises to be the most eagerly awaited event of its type in this sector.

The experience and seniority of the speakers shows the levels at which Forecasting is now taken in the Pharma Industry and clearly positions 'Forecasting' at the heart of Major Pharma companies business strategy development.

As an aid to this important event eyeforpharma is offering a free report called 'Deliver Pharmaceutical Forecasting Excellence'

This report is based on a survey conducted by eyeforpharma. More than 3000 senior pharma executives took part, representing the world's leading producers of ethical drugs, generics and OTC products. To gain a more detailed insight into the trends and challenges facing the forecaster.

The study is designed to

  • Show how pharmaceutical companies review their current forecasting models
  • Deliver unique insights on how Big Pharma are combining innovative strategies with basic models for competitive edge
  • Provide a roadmap for developing a forecasting excellence

For further information visit www.eyeforpharma.com/forecastingusa07

About eyeforpharma
eyeforpharma is a global pharmaceutical business strategy information provider with a highly reputable and worldwide presence in the Pharma industry. It is renowned for producing top level conferences that attract the highest level of speakers to deliver presentations on cutting edge pharmaceutical business strategies. We provide business intelligence and analysis online at www.eyeforpharma.com and through an email briefing twice a month. eyeforpharma also has a very strong foothold in the European, US and Japanese markets.

Most Popular Now

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

The fourth COVID-19 vaccine reduces the risk of de…

A new study by Tel Aviv University and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that the fourth COVID-19 vaccin...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Research shows investigational drug fosters nerve …

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of da...

NIH launches clinical trial of mRNA Nipah virus va…

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an inv...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...